Chemicals that activate CB2 may have anti-addictive properties.
CBD could protect against hypoxic ischemia, a complication that prevents a baby from getting enough oxygen during birth.
A new study suggests an antipsychotic called haloperidol decreases the psychoactive effects of THC.
Most cannabis supplied by the U.S. government for research has less than 10% THC and may be over a year old.
This study shows that measuring a compound’s affinity for CB1 should be done at multiple time points.
Researchers at the University of Washington recently reviewed 2-AG’s role in endocannabinoid signaling.
Two contradictory studies underscores why preclinical research is only a first step.
A study from Spain indicates that the ECS plays an important role in the treatment of HER2-positive cancer.
A comparison of the antitumoral activity of single-molecule THC and whole plant cannabis oil.
Preclinical studies don’t always provide precise, controllable, and translational models for human diseases.